Skip to Main Content

Author Details

Jason T Yustein
1998
62
25
PMIDPaper TitleJournal TitlePublished Year
37511127Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis.2023
35676822Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer.Cancer Medicine2023
38014160Intrinsic epigenetic state of primary osteosarcoma drives metastasis.2023
37894474Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis.2023
37279073MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma.2023
37018203Toward quantification of hypoxia using fluorinated Eu-containing ratiometric probes.2023
36799651Modeling Ewing Sarcoma Lung Metastasis.2023
35174853K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications.Dis Model Mech2022
36348010LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and TSC2 ubiquitination.Oncogene2022
35884281Dual-Mode Tumor Imaging Using Probes That Are Responsive to Hypoxia-Induced Pathological Conditions.Biosensors2022
36005011A Mouse Holder for Awake Functional Imaging in Unanesthetized Mice: Applications in P Spectroscopy, Manganese-Enhanced Magnetic Resonance Imaging Studies, and Resting-State Functional Magnetic Resonance Imaging.Biosensors2022
35732731cBAF complex components and MYC cooperate early in CD8<sup>+</sup> T cell fate.Nature2022
35412907Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies.Proc Natl Acad Sci U S A2022
36115869An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.NPJ Precis Oncol2022
36451687Osteogenesis in the presence of chemotherapy: A biomimetic approach.Journal of Tissue Engineering2022
34421639Upregulation of miR181a/miR212 Improves Myogenic Commitment in Murine Fusion-Negative Rhabdomyosarcoma.Frontiers in Physiology2021
36594908PAK1 and PAK4 as therapeutic targets for Ewing sarcoma: a commentary.2021
34070758Overcoming PD-1 Inhibitor Resistance with a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma.Cancers2021
33475101Magnetic resonance thermometry using a Gd-based contrast agent.Chemical Communications2021
33792560Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells.Journal of Clinical Investigation2021
33829146Engineering Oncolytic Vaccinia Virus to redirect Macrophages to Tumor Cells.Adv Cell Gene Ther2021
34022967Research models and mesenchymal/epithelial plasticity of osteosarcoma.Cell and Bioscience2021
33168646Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma.Cancer Research2021
33414491p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma.Oncogene2021
35019338Reproducible and Characterized Method for Ponatinib Encapsulation into Biomimetic Lipid Nanoparticles as a Platform for Multi-Tyrosine Kinase-Targeted Therapy.ACS Applied Bio Materials2020
31672491Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.Cancer Lett2020
33396725Recent Insights into Therapy Resistance in Osteosarcoma.Cancers2020
30793158Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.Journal of the National Cancer Institute2019
35582574Long non-coding RNAs regulation of therapeutic resistance.Cancer Drug Resistance2019
31836741MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin.Scientific Reports2019
30548185Generation of patient-derived tumor xenografts from percutaneous tumor biopsies in children with bone sarcomas.Pediatric Blood and Cancer2019
31031965Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children's Oncology Group (COG) New Agents for Ewing Sarcoma Task Force.F1000Res2019
31515721Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo.Annals of Surgical Oncology2019
29086373Detection of Plasma MicroRNA Signature in Osteosarcoma Patients.Methods in Molecular Biology2018
30323968Transglutaminase-2 promotes metastatic and stem-like phenotypes in osteosarcoma.Am J Cancer Res2018
29534895In Vitro and In Vivo Characterization of a Preclinical Irradiation-Adapted Model for Ewing Sarcoma.International Journal of Radiation Oncology Biology Physics2018
29780447Fluorinated Eu-based multimodal contrast agent for temperature- and redox-responsive magnetic resonance imaging.Chemical Science2017
28748534miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma.Int J Cancer2017
29100387Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties.Oncotarget2017
29228567Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma.Oncotarget2017
28025559Cancer's Achilles' Heel: Apoptosis and Necroptosis to the Rescue.International Journal of Molecular Sciences2016
27294526Glycolysis determines dichotomous regulation of T cell subsets in hypoxia.Journal of Clinical Investigation2016
27821163Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.BMC Cancer2016
26528706Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.Br J Cancer2015
25784290Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma.Cancer Med2015
25579177NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma.Oncogene2015
26355645Coamplification of Myc/Pvt1 and homozygous deletion of Nlrp1 locus are frequent genetics changes in mouse osteosarcoma.Genes Chromosomes Cancer2015
23331017Multiple target-specific molecular agents for detection and image analysis of breast cancer characteristics in mice.Current Molecular Medicine2013
23690089The adolescent and young adult with cancer: state of the art -- bone tumors.Current Oncology Reports2013
23486780Proteoglycan 4 expression protects against the development of osteoarthritis.Science Translational Medicine2013
  • 1 - 50 of 62

Recommended Authors

Collaborators

Baylor College of Medicine
Co-authored papers 8
Johns Hopkins University School of Medicine
Co-authored papers 6
Baylor College of Medicine
Co-authored papers 3
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Co-authored papers 3
The Ohio State University College of Medicine
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Children's Hospital at Montefiore.
Co-authored papers 2
Keck School of Medicine of the University of Southern California
Co-authored papers 2
Co-authored papers 2
Children's Hospital of Philadelphia.
Co-authored papers 2
Georgetown University Medical Center, Georgetown University
Co-authored papers 2
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Balgrist University Hospital, University of Zurich (UZH)
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Hoag Memorial Hospital Presbyterian
Co-authored papers 1
Cancer Center of Lyon
Co-authored papers 1
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Co-authored papers 1
The First Affiliated Hospital of Guangxi Medical University
Co-authored papers 1
Co-authored papers 1
German Cancer Research Center
Co-authored papers 1
Co-authored papers 1
Harvard Medical School
Co-authored papers 1